Buy

BMRN Quote, Financials, Valuation and Earnings

Last price:

$70.69

Seasonality move :

2.18%

Day range:

$69.05 - $71.28

52-week range:

$60.63 - $94.85

Dividend yield:

0%

P/E ratio:

32.13x

P/S ratio:

4.91x

P/B ratio:

2.38x

Volume:

1.6M

Avg. volume:

1.6M

1-year change:

-19.06%

Market cap:

$13.5B

Revenue:

$2.9B

EPS (TTM):

$2.20

Biomarin Pharmaceutical SEC Filings

Company	Filed	Form Type	Description
BMRN Biomarin Pharmaceutical	04/26/2024	10-Q	10-Q filing on 04/26/2024	View Form
BMRN Biomarin Pharmaceutical	02/26/2024	10-K	10-K filing on 02/26/2024	View Form
BMRN Biomarin Pharmaceutical	11/02/2023	10-Q	10-Q filing on 11/02/2023	View Form
BMRN Biomarin Pharmaceutical	08/02/2023	10-Q	10-Q filing on 08/02/2023	View Form
BMRN Biomarin Pharmaceutical	04/28/2023	10-Q	10-Q filing on 04/28/2023	View Form
BMRN Biomarin Pharmaceutical	02/27/2023	10-K	10-K filing on 02/27/2023	View Form
BMRN Biomarin Pharmaceutical	10/28/2022	10-Q	10-Q filing on 10/28/2022	View Form
BMRN Biomarin Pharmaceutical	08/04/2022	10-Q	10-Q filing on 08/04/2022	View Form
BMRN Biomarin Pharmaceutical	04/29/2022	10-Q	10-Q filing on 04/29/2022	View Form
BMRN Biomarin Pharmaceutical	02/25/2022	10-K	10-K filing on 02/25/2022	View Form
BMRN Biomarin Pharmaceutical	10/29/2021	10-Q	10-Q filing on 10/29/2021	View Form
BMRN Biomarin Pharmaceutical	07/30/2021	10-Q	10-Q filing on 07/30/2021	View Form
BMRN Biomarin Pharmaceutical	04/30/2021	10-Q	10-Q filing on 04/30/2021	View Form
BMRN Biomarin Pharmaceutical	02/26/2021	10-K	10-K filing on 02/26/2021	View Form
BMRN Biomarin Pharmaceutical	11/06/2020	10-Q	10-Q filing on 11/06/2020	View Form
BMRN Biomarin Pharmaceutical	08/05/2020	10-Q	10-Q filing on 08/05/2020	View Form
BMRN Biomarin Pharmaceutical	05/01/2020	10-Q	10-Q filing on 05/01/2020	View Form
BMRN Biomarin Pharmaceutical	02/27/2020	10-K	10-K filing on 02/27/2020	View Form
BMRN Biomarin Pharmaceutical	11/04/2019	10-Q	10-Q filing on 11/04/2019	View Form
BMRN Biomarin Pharmaceutical	10/29/2019	10-Q	10-Q filing on 10/29/2019	View Form
BMRN Biomarin Pharmaceutical	08/02/2019	10-Q	10-Q filing on 08/02/2019	View Form
BMRN Biomarin Pharmaceutical	04/29/2019	10-Q	10-Q filing on 04/29/2019	View Form
BMRN Biomarin Pharmaceutical	02/28/2019	10-K	10-K filing on 02/28/2019	View Form
BMRN Biomarin Pharmaceutical	10/26/2018	10-Q	10-Q filing on 10/26/2018	View Form
BMRN Biomarin Pharmaceutical	08/03/2018	10-Q	10-Q filing on 08/03/2018	View Form
BMRN Biomarin Pharmaceutical	04/27/2018	10-Q	10-Q filing on 04/27/2018	View Form
BMRN Biomarin Pharmaceutical	02/26/2018	10-K	10-K filing on 02/26/2018	View Form
BMRN Biomarin Pharmaceutical	11/13/2017	10-Q	10-Q filing on 11/13/2017	View Form
BMRN Biomarin Pharmaceutical	10/31/2017	10-Q	10-Q filing on 10/31/2017	View Form
BMRN Biomarin Pharmaceutical	08/02/2017	10-Q	10-Q filing on 08/02/2017	View Form
BMRN Biomarin Pharmaceutical	05/04/2017	10-Q	10-Q filing on 05/04/2017	View Form
BMRN Biomarin Pharmaceutical	02/27/2017	10-K	10-K filing on 02/27/2017	View Form
BMRN Biomarin Pharmaceutical	11/03/2016	10-Q	10-Q filing on 11/03/2016	View Form
BMRN Biomarin Pharmaceutical	08/08/2016	10-Q	10-Q filing on 08/08/2016	View Form
BMRN Biomarin Pharmaceutical	05/02/2016	10-Q	10-Q filing on 05/02/2016	View Form
BMRN Biomarin Pharmaceutical	02/29/2016	10-K	10-K filing on 02/29/2016	View Form
BMRN Biomarin Pharmaceutical	11/02/2015	10-Q	10-Q filing on 11/02/2015	View Form
BMRN Biomarin Pharmaceutical	08/05/2015	10-Q	10-Q filing on 08/05/2015	View Form
BMRN Biomarin Pharmaceutical	05/05/2015	10-Q	10-Q filing on 05/05/2015	View Form

Related Companies

Get BMRN Stock Alert

Signup to receive the latest stock alerts

Financial Ratios

BMRN

Sector

P/E ratio

32.13x

24.26x

PEG ratio

0.21x

0.00x

P/B ratio

2.38x

1.67x

Price / LTM sales

4.91x

1.69x

Growth Metrics

BMRN

Sector

Revenue growth

15.65%

6.42%

Earnings growth

481.82%

6.56%

Revenue (5-year growth)

10.86%

8.84%

Earnings forecast

$0.97

-$0.19

Profitability

BMRN

Sector

Profitability FY 2024

$2.3B

$56.7M

Return on invested capital

6.92%

-14.34%

Return on assets

6.17%

-11.83%

Return on equity

8.09%

-16.73%

Earnings Date

Last Earnings Date

Feb

19

Next Earnings Date

Apr

24

Estimated Next Earnings Date

May

21

Balance Sheet

BMRN

Sector

Total cash

$1.1B

$41.7M

Short term investments

$194.9M

$39.3M

Total assets

$7B

$125M

Long term debt

$595.1M

$10.4M

Stock Ideas

Buy

56

Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Buy or Sell?

Sell

46

Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Buy or Sell?

Sell

41

Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 37x

Buy or Sell?

Alerts

Buy

80

CORT alert for Apr 1

Corcept Therapeutics [CORT] is up 109.21% over the past day.

Buy or Sell?

Sell

40

RGC alert for Mar 31

Regencell Bioscience Holdings [RGC] is up 26.1% over the past day.

Buy or Sell?

Buy

74

COOP alert for Apr 1

Mr. Cooper Group [COOP] is up 14.4% over the past day.

Buy or Sell?

Master Safe Stock Market Strategies

Get Paid To Own Stocks. Insure Your Stocks During Downtrends. Master "The Vacation Trade".

Biomarin Pharmaceutical SEC Filings

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Related Companies

Get BMRN Stock Alert

Financial Ratios

Growth Metrics

Profitability

Earnings Date

Balance Sheet

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Could IBIT Go?

Is Raymond James Stock a Buy, Sell or Hold?

Is JHX Stock a Buy Sell or Hold?

Stock Ideas

Is AAPL Stock a Buy?

Is MSFT Stock a Buy?

Is NVDA Stock a Buy?

Alerts

CORT alert for Apr 1

RGC alert for Mar 31

COOP alert for Apr 1

THE #1 STOCK ANALYSIS TOOLTO MAKE SMARTER BUY AND SELL DECISIONS

Watchlist

Stock Score

Seasonality

Analyze

Covered Calls

Valuation

Smart Money

Education

E-Book

Newsletters

Companies

Dividends

Traders Library

Big Movers

Stock Ideas

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS